Biomarkers in Alzheimer’s disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disease. AD is the main cause of dementia worldwide and aging is the main risk factor for developing the illness. AD classical diagnostic criteria rely on clinical data. However, the development of a biological definition of AD using biomar...
Guardado en:
Autores principales: | Janeiro Manuel H., Ardanaz Carlos G., Sola-Sevilla Noemí, Dong Jinya, Cortés-Erice María, Solas Maite, Puerta Elena, Ramírez María J. |
---|---|
Formato: | article |
Lenguaje: | EN ES |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6b9b9b2d980447d95839b69089cbe11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarcadores en la enfermedad de Alzheimer
por: Janeiro Manuel H., et al.
Publicado: (2021) -
Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
por: Donoso,Archibaldo, et al.
Publicado: (2001) -
The Potential of Naturalistic Eye Movement Tasks in the Diagnosis of Alzheimer’s Disease: A Review
por: Megan Rose Readman, et al.
Publicado: (2021) -
Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis
por: Elisabet Lopez-Soley, et al.
Publicado: (2021) -
More accurate systolic blood pressure measurement is required for improved hypertension management: a perspective
por: Nitzan M, et al.
Publicado: (2017)